Abstract
The cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel is a membrane-integral protein that belongs to the ATP-binding cassette superfamily. Mutations in the CFTR gene cause cystic fibrosis in which salt, water, and protein transports are defective in various tissues. To investigate the conformation of the CFTR in the membrane, we applied the small-angle x-ray scattering (SAXS) technique on microsomal membranes extracted from NIH/3T3 cells permanentely transfected with wild-type (WT) CFTR and with CFTR carrying the ΔF508 mutation. The electronic density profile of the membranes was calculated from the SAXS data, assuming the lipid bilayer electronic density to be composed by a series of Gaussian shells. The data indicate that membranes in the microsome vesicles, that contain mostly endoplasmic reticulum membranes, are oriented in the outside-out conformation. Phosphorylation does not change significantly the electronic density profile, while dephosphorylation produces a significant modification in the inner side of the profile. Thus, we conclude that the CFTR and its associated protein complex in microsomes are mostly phosphorylated. The electronic density profile of the ΔF508-CFTR microsomes is completely different from WT, suggesting a different assemblage of the proteins in the membranes. Low-temperature treatment of cells rescues the ΔF508-CFTR protein, resulting in a conformation that resembles the WT. Differently, treatment with the corrector VX-809 modifies the electronic profile of ΔF508-CFTR membrane, but does not recover completely the WT conformation. To our knowledge, this is the first report of a direct physical measurement of the structure of membranes containing CFTR in its native environment and in different functional and pharmacological conditions.
Similar content being viewed by others
References
Awayn NH, Rosenberg MF, Kamis AB, Aleksandrov LA, Riordan JR, Ford RC (2005) Crystallographic and single-particle analyses of native- and nucleotide-bound forms of the cystic fibrosis transmembrane conductance regulator (CFTR) protein. Biochem Soc Trans 33:996–999
Rosenberg MF, Kamis AB, Aleksandrov LA, Ford RC, Riordan JR (2004) Purification and crystallization of the cystic fibrosis transmembrane conductance regulator (CFTR). J Biol Chem 279:39051–39057
Rosenberg MF, O’Ryan LP, Hughes G, Zhao Z, Aleksandrov LA, Riordan JR, Ford RC (2011) The cystic fibrosis transmembrane conductance regulator (CFTR): three-dimensional structure and localization of a channel gate. J Biol Chem 286:42647–42654
Zhang L, Aleksandrov LA, Zhao Z, Birtley JR, Riordan JR, Ford RC (2009) Architecture of the cystic fibrosis transmembrane conductance regulator protein and structural changes associated with phosphorylation and nucleotide binding. J Struct Biol 167:242–251
Marasini C, Galeno L, Moran O (2013) A SAXS-based ensemble model of the native and phosphorylated regulatory domain of the CFTR. Cell Mol Life Sci 70:923–933
Galeno L, Galfrè E, Moran O (2011) Small-angle X-ray scattering study of the ATP modulation of the structural features of the nucleotide binding domains of the CFTR in solution. Eur Biophys J 40:811–824
Galfrè E, Galeno L, Moran O (2012) A potentiator induces conformational changes on the recombinant CFTR nucleotide binding domains in solution. Cell Mol Life Sci 69:3701–3713
Atwell S, Brouillette CG, Conners K, Emtage S, Gheyi T, Guggino WB, Hendle J, Hunt JF, Lewis HA, Lu F, Protasevich II, Rodgers LA, Romero R, Wasserman SR, Weber PC, Wetmore D, Zhang FF, Zhao X (2010) Structures of a minimal human CFTR first nucleotide-binding domain as a monomer, head-to-tail homodimer, and pathogenic mutant. Protein Eng Des Sel 23:375–384
Lewis HA, Buchanan SG, Burley SK, Conners K, Dickey M, Dorwart M, Fowler R, Gao X, Guggino WB, Hendrickson WA, Hunt JF, Kearins MC, Lorimer D, Maloney PC, Post KW, Rajashankar KR, Rutter ME, Sauder JM, Shriver S, Thibodeau PH, Thomas PJ, Zhang M, Zhao X, Emtage S (2004) Structure of nucleotide-binding domain 1 of the cystic fibrosis transmembrane conductance regulator. EMBO J 23:282–293
Lewis HA, Zhao X, Wang C, Sauder JM, Rooney I, Noland BW, Lorimer D, Kearins MC, Conners K, Condon B, Maloney PC, Guggino WB, Hunt JF, Emtage S (2005) Impact of the DeltaF508 mutation in first nucleotide-binding domain of human cystic fibrosis transmembrane conductance regulator on domain folding and structure. J Biol Chem 280:1346–1353
Mertens HDT, Svergun DI (2010) Structural characterization of proteins and complexes using small-angle X-ray solution scattering. J Struct Biol 172:128–141
Stuhrmann HB (2008) Small-angle scattering and its interplay with crystallography, contrast variation in SAXS and SANS. Acta Crystallogr A 64:181–191
Sano Y, Inoue H, Kajiwara K, Hiragi Y, Isoda S (1997) Structural analysis of A-protein of cucumber green mottle mosaic virus and tobacco mosaic virus by synchrotron small-angle X-ray scattering. J Protein Chem 16:151–159
Svergun DI, Burkhardt N, Pedersen JS, Koch MH, Volkov VV, Kozin MB, Meerwink W, Stuhrmann HB, Diedrich G, Nierhaus KH (1997) Solution scattering structural analysis of the 70 S Escherichia coli ribosome by contrast variation. II. A model of the ribosome and its RNA at 3.5 nm resolution. J Mol Biol 271:602–618
Castorph S, Riedel D, Arleth L, Sztucki M, Jahn R, Holt M, Salditt T (2010) Structure parameters of synaptic vesicles quantified by small-angle x-ray scattering. Biophys J 98:1200–1208
Aleksandrov L, Mengos A, Chang X, Aleksandrov A, Riordan JR (2001) Differential interactions of nucleotides at the two nucleotide binding domains of the cystic fibrosis transmembrane conductance regulator. J Biol Chem 276:12918–12923
Gunderson KL, Kopito RR (1994) Effects of pyrophosphate and nucleotide analogs suggest a role for ATP hydrolysis in cystic fibrosis transmembrane regulator channel gating. J Biol Chem 269:19349–19353
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
Körschen HG, Yildiz Y, Raju DN, Schonauer S, Bönigk W, Jansen V, Kremmer E, Kaupp UB, Wachten D (2013) The non-lysosomal β-glucosidase GBA2 is a non-integral membrane-associated protein at the endoplasmic reticulum (ER) and Golgi. J Biol Chem 288:3381–3393
Kong E, Peng S, Chandra G, Sarkar C, Zhang Z, Bagh MB, Mukherjee AB (2013) Dynamic palmitoylation links cytosol-membrane shuttling of acyl-protein thioesterase-1 and acyl-protein thioesterase-2 with that of proto-oncogene H-ras product and growth-associated protein-43. J Biol Chem 288:9112–9125
Mondini A, Sassone F, Civello DA, Garavaglia ML, Bazzini C, Rodighiero S, Vezzoli V, Conti F, Torielli L, Capasso G, Paulmichl M, Meyer G (2012) Hypertension-linked mutation of α-adducin increases CFTR surface expression and activity in HEK and cultured rat distal convoluted tubule cells. PLoS One 7:e52014
Nakamura N, Rabouille C, Watson R, Nilsson T, Hui N, Slusarewicz P, Kreis TE, Warren G (1995) Characterization of a cis-Golgi matrix protein, GM130. J Cell Biol 131:1715–1726
Guinier A (1994) X-ray Diffraction in Crystals, Imperfect Crystals, and Amorphous Bodies. Courier Dover Publications, San Francisco and London
Brzustowicz MR, Brunger AT (2005) X-ray scattering from unilamellar lipid vesicles. J Appl Cryst 38:126–131
Wibo M, Amar-Costesec A, Berthet J, Beaufay H (1971) Electron microscope examination of subcellular fractions. 3. Quantitative analysis of the microsomal fraction isolated from rat liver. J Cell Biol 51:52–71
Lavoie C, Lanoix J, Kan FW, Paiement J (1996) Cell-free assembly of rough and smooth endoplasmic reticulum. J Cell Sci 109(Pt 6):1415–1425
Castorph S, Arleth L, Sztucki M, Vainio U, Ghosh SK, Holt M, Jahn R, Salditt T (2010) Synaptic vesicles studied by SAXS: derivation and validation of a model form factor. J Phys Conf Ser 247:012015
Baroni D, Zegarra-Moran O, Svensson A, Moran O (2014) Direct interaction of a CFTR potentiator and a CFTR corrector with phospholipid bilayers. Eur Biophys J 43:341–346
Pabst G, Rappolt M, Amenitsch H, Laggner P (2000) Structural information from multilamellar liposomes at full hydration: full q-range fitting with high-quality X-ray data. Phys Rev E 62:4000–4009
De Duve C (1971) Tissue fractionation past and present. J Cell Biol 50:20d–55d
Palade GE, Siekevits P (1956) Liver microsomes: an integrated morphological and biochemical study. J Biophys Biochem Cytol. 2:171–200
Blouin A, Bolender RP, Weibel ER (1977) Distribution of organelles and membranes between hepatocytes and nonhepatocytes in the rat liver parenchyma. A stereological study. J Cell Biol 72:441–455
Croze EM, Morré DJ (1984) Isolation of plasma membrane, golgi apparatus, and endoplasmic reticulum fractions from single homogenates of mouse liver. J Cell Physiol 119:46–57
Saeger W, Rübenach-Gerz K, Caselitz J, Lüdecke DK (1987) Electron microscopical morphometry of GH producing pituitary adenomas in comparison with normal GH cells. Virchows Arch A Pathol Anat Histopathol 411:467–472
Navas P, Nowack DD, Morré DJ (1989) Isolation of purified plasma membranes from cultured cells and hepatomas by two-phase partition and preparative free-flow electrophoresis. Cancer Res 49:2147–2156
Moran O (2014) On the structural organization of the intracellular domains of CFTR. Int J Biochem Cell Biol 52C:7–14
Wang X, Venable J, LaPointe P, Hutt DM, Koulov AV, Coppinger J, Gurkan C, Kellner W, Matteson J, Plutner H, Riordan JR, Kelly JW, Yates JR, Balch WE (2006) Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis. Cell 127:803–815
Ahner A, Gong X, Frizzell RA (2013) Cystic fibrosis transmembrane conductance regulator degradation: cross-talk between the ubiquitylation and SUMOylation pathways. FEBS J 280:4430–4438
Edelman A (2014) Cytoskeleton and CFTR. Int J Biochem Cell Biol 52C:68–72
Pranke IM, Sermet-Gaudelus I (2014) Biosynthesis of cystic fibrosis transmembrane conductance regulator. Int J Biochem Cell Biol 52C:26–38
Zhang F, Kartner N, Lukacs GL (1998) Limited proteolysis as a probe for arrested conformational maturation of delta F508 CFTR. Nat Struct Biol 5:180–183
Bouwstra JA, Gooris GS, Bras W, Talsma H (1993) Small angle X-ray scattering: possibilities and limitations in characterization of vesicles. Chem Phys Lipids 64:83–98
Hirai M, Iwase H, Hayakawa T, Koizumi M, Takahashi H (2003) Determination of asymmetric structure of ganglioside-DPPC mixed vesicle using SANS, SAXS, and DLS. Biophys J 85:1600–1610
Herbette L, Scarpa A, Blasie JK, Wang CT, Saito A, Fleischer S (1981) Comparison of the profile structures of isolated and reconstituted sarcoplasmic reticulum membranes. Biophys J 36:47–72
Chang XB, Hou YX, Riordan JR (1997) ATPase activity of purified multidrug resistance-associated protein. J Biol Chem 272:30962–30968
Rich DP, Berger HA, Cheng SH, Travis SM, Saxena M, Smith AE, Welsh MJ (1993) Regulation of the cystic fibrosis transmembrane conductance regulator Cl- channel by negative charge in the R domain. J Biol Chem 268:20259–20267
Rich DP, Gregory RJ, Anderson MP, Manavalan P, Smith AE, Welsh MJ (1991) Effect of deleting the R domain on CFTR-generated chloride channels. Science 253:205–207
Dulhanty AMRJ (1994) Phosphorylation by cAMP-dependent protein kinase causes a conformational change in the R domain of the cystic fibrosis transmembrane conductance regulator. Biochemistry 33:4072–4079
Kanelis V, Hudson RP, Thibodeau PH, Thomas PJ, Forman-Kay JD (2010) NMR evidence for differential phosphorylation-dependent interactions in WT and DeltaF508 CFTR. EMBO J 29:263–277
Marasini C, Galeno L, Moran O (2012) Thermodynamic study of the native and phosphorylated regulatory domain of the CFTR. Biochem Biophys Res Commun 423:549–552
Baker JMR, Hudson RP, Kanelis V, Choy W, Thibodeau PH, Thomas PJ, Forman-Kay JD (2007) CFTR regulatory region interacts with NBD1 predominantly via multiple transient helices. Nat Struct Mol Biol 14:738–745
Lukacs GL, Chang XB, Bear C, Kartner N, Mohamed A, Riordan JR, Grinstein S (1993) The delta F508 mutation decreases the stability of cystic fibrosis transmembrane conductance regulator in the plasma membrane. Determination of functional half-lives on transfected cells. J Biol Chem 268:21592–21598
Sharma M, Benharouga M, Hu W, Lukacs GL (2001) Conformational and temperature-sensitive stability defects of the delta F508 cystic fibrosis transmembrane conductance regulator in post-endoplasmic reticulum compartments. J Biol Chem 276:8942–8950
Thibodeau PH, Richardson JM, Wang W, Millen L, Watson J, Mendoza JL, Du K, Fischman S, Senderowitz H, Lukacs GL, Kirk K, Thomas PJ (2010) The cystic fibrosis-causing mutation deltaF508 affects multiple steps in cystic fibrosis transmembrane conductance regulator biogenesis. J Biol Chem 285:35825–35835
Du K, Sharma M, Lukacs GL (2005) The DeltaF508 cystic fibrosis mutation impairs domain-domain interactions and arrests post-translational folding of CFTR. Nat Struct Mol Biol 12:17–25
Pedemonte N, Lukacs GL, Du K, Caci E, Zegarra-Moran O, Galietta LJ, Verkman AS (2005) Small-molecule correctors of defective DeltaF508-CFTR cellular processing identified by high-throughput screening. J Clin Invest. 115:2564–2571 Epub 2005 Aug 25
Jurkuvenaite A, Chen L, Bartoszewski R, Goldstein R, Bebok Z, Matalon S, Collawn JF (2010) Functional stability of rescued delta F508 cystic fibrosis transmembrane conductance regulator in airway epithelial cells. Am J Respir Cell Mol Biol 42:363–372
Rowe SM, Pyle LC, Jurkevante A, Varga K, Collawn J, Sloane PA, Woodworth B, Mazur M, Fulton J, Fan L, Li Y, Fortenberry J, Sorscher EJ, Clancy JP (2010) DeltaF508 CFTR processing correction and activity in polarized airway and non-airway cell monolayers. Pulm Pharmacol Ther 23:268–278
Dalemans W, Barbry P, Champigny G, Jallat S, Dott K, Dreyer D, Crystal RG, Pavirani A, Lecocq JP, Lazdunski M (1991) Altered chloride ion channel kinetics associated with the delta F508 cystic fibrosis mutation. Nature 354:526–528
Haws CM, Nepomuceno IB, Krouse ME, Wakelee H, Law T, Xia Y, Nguyen H, Wine JJ (1996) Delta F508-CFTR channels: kinetics, activation by forskolin, and potentiation by xanthines. Am J Physiol 270:C1544–C1555
Jih K, Li M, Hwang T, Bompadre SG (2011) The most common cystic fibrosis-associated mutation destabilizes the dimeric state of the nucleotide-binding domains of CFTR. J Physiol 589:2719–2731
Acknowledgements
This work was partially supported by the Fondazione per la Ricerca sulla Fibrosi Cistica, grant FFC#4/2012. These experiments were performed at the BL11-NCD beamline of ALBA Synchrotron Light Facility with financial support of the facility and the collaboration of ALBA staff. We thank Marc Malfois, Agneta Svenson and Christina Kamma-Lorger for the technical assistance at the synchrotron beamline. We are indebted to Dr. Cristina D’Arrigo for helping with the EM experiments. We thank also Alessandro Barbin for the construction of the sample cell for SAXS.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Baroni, D., Zegarra-Moran, O. & Moran, O. Functional and pharmacological induced structural changes of the cystic fibrosis transmembrane conductance regulator in the membrane solved using SAXS. Cell. Mol. Life Sci. 72, 1363–1375 (2015). https://doi.org/10.1007/s00018-014-1747-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00018-014-1747-4